Ataxic vs painful form of paraneoplastic neuropathy

To characterize the clinicopathologic features of ataxic and painful forms of paraneoplastic neuropathy. Clinical, electrophysiologic, and histopathologic findings were assessed in 17 patients with paraneoplastic neuropathy. Clinical features can be categorized into two groups: one group (13 patient...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neurology 2007-08, Vol.69 (6), p.564-572
Hauptverfasser: OKI, Y, KOIKE, H, YAZAKI, S, NOKURA, K, YAMAMOTO, H, SOBUE, G, IIJIMA, M, MORI, K, HATTORI, N, KATSUNO, M, NAKAMURA, T, HIRAYAMA, M, TANAKA, F, SHIRAISHI, M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 572
container_issue 6
container_start_page 564
container_title Neurology
container_volume 69
creator OKI, Y
KOIKE, H
YAZAKI, S
NOKURA, K
YAMAMOTO, H
SOBUE, G
IIJIMA, M
MORI, K
HATTORI, N
KATSUNO, M
NAKAMURA, T
HIRAYAMA, M
TANAKA, F
SHIRAISHI, M
description To characterize the clinicopathologic features of ataxic and painful forms of paraneoplastic neuropathy. Clinical, electrophysiologic, and histopathologic findings were assessed in 17 patients with paraneoplastic neuropathy. Clinical features can be categorized into two groups: one group (13 patients) with predominantly deep sensory disturbance and a second group (4 patients) with predominantly superficial sensory disturbance. The former group showed severe sensory ataxia and predominantly large myelinated fiber loss in the sural nerve. The latter group showed marked pain, in particular, severe mechanical hyperalgesia, and predominantly small myelinated and unmyelinated fiber loss. Nerve conduction assessment indicated an axonal neuropathy pattern in both groups, while sensory action potentials were more markedly diminished in the sensory ataxic form. Anti-Hu antibodies were detected in half of the patients in both groups. Treatment for cancer was effective to improve or stabilize neuropathic symptoms in some cases from both groups. Immunotherapy was effective only for a short time. Paraneoplastic neuropathy can be characterized into two groups by the presence of sensory ataxia or severe spontaneous pain and severe mechanical hyperalgesia. Preferential small myelinated and unmyelinated fiber loss correlated to the cases of severe pain.
doi_str_mv 10.1212/01.wnl.0000266668.03638.94
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68134977</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68134977</sourcerecordid><originalsourceid>FETCH-LOGICAL-c444t-f9ee56e424d386614486cfdba9d6465a74a0304bb815a6642c6e68c567463d353</originalsourceid><addsrcrecordid>eNqFkEtLxDAQgIMo7rr6F2QR9NaaNJNJ4k0WX7DgRcFbSNMUK91tbVp1_71Zt7BH5zIM882Dj5ALRlOWseyasvR7Xac0RoYxVEo5cpVqOCBTJjJMkGdvh2Qa-yrhSqoJOQnhg9LYlPqYTJhEqVGKKeG3vf2p3PwrzFtbrcuhnpdNt5o3Zaw7u_ZNW9vQR2Lth65pbf--OSVHpa2DPxvzjLze370sHpPl88PT4naZOADok1J7L9BDBgVXiAxAoSuL3OoCAYWVYCmnkOeKCYsImUOPygmUgLzggs_I1W5v2zWfgw-9WVXB-brevjUEg4px0FL-CzItZMYEjeDNDnRdE0LnS9N21cp2G8Oo2bo1lJno1uzdmj-3RkMcPh-vDPnKF_vRUWYELkfABmfrMupzVdhzmjIJHPgv38OBww</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19572150</pqid></control><display><type>article</type><title>Ataxic vs painful form of paraneoplastic neuropathy</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><source>Alma/SFX Local Collection</source><creator>OKI, Y ; KOIKE, H ; YAZAKI, S ; NOKURA, K ; YAMAMOTO, H ; SOBUE, G ; IIJIMA, M ; MORI, K ; HATTORI, N ; KATSUNO, M ; NAKAMURA, T ; HIRAYAMA, M ; TANAKA, F ; SHIRAISHI, M</creator><creatorcontrib>OKI, Y ; KOIKE, H ; YAZAKI, S ; NOKURA, K ; YAMAMOTO, H ; SOBUE, G ; IIJIMA, M ; MORI, K ; HATTORI, N ; KATSUNO, M ; NAKAMURA, T ; HIRAYAMA, M ; TANAKA, F ; SHIRAISHI, M</creatorcontrib><description>To characterize the clinicopathologic features of ataxic and painful forms of paraneoplastic neuropathy. Clinical, electrophysiologic, and histopathologic findings were assessed in 17 patients with paraneoplastic neuropathy. Clinical features can be categorized into two groups: one group (13 patients) with predominantly deep sensory disturbance and a second group (4 patients) with predominantly superficial sensory disturbance. The former group showed severe sensory ataxia and predominantly large myelinated fiber loss in the sural nerve. The latter group showed marked pain, in particular, severe mechanical hyperalgesia, and predominantly small myelinated and unmyelinated fiber loss. Nerve conduction assessment indicated an axonal neuropathy pattern in both groups, while sensory action potentials were more markedly diminished in the sensory ataxic form. Anti-Hu antibodies were detected in half of the patients in both groups. Treatment for cancer was effective to improve or stabilize neuropathic symptoms in some cases from both groups. Immunotherapy was effective only for a short time. Paraneoplastic neuropathy can be characterized into two groups by the presence of sensory ataxia or severe spontaneous pain and severe mechanical hyperalgesia. Preferential small myelinated and unmyelinated fiber loss correlated to the cases of severe pain.</description><identifier>ISSN: 0028-3878</identifier><identifier>EISSN: 1526-632X</identifier><identifier>DOI: 10.1212/01.wnl.0000266668.03638.94</identifier><identifier>PMID: 17679675</identifier><identifier>CODEN: NEURAI</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott Williams &amp; Wilkins</publisher><subject>Action Potentials ; Aged ; Antibodies, Neoplasm - immunology ; Antineoplastic Agents - therapeutic use ; Autoantibodies - immunology ; Autoantigens - immunology ; Biological and medical sciences ; Biopsy ; Cranial nerves. Spinal roots. Peripheral nerves. Autonomic nervous system. Gustation. Olfaction ; Female ; Gait Ataxia - etiology ; Humans ; Hypesthesia - etiology ; Hypesthesia - pathology ; Lung Neoplasms - complications ; Male ; Medical sciences ; Middle Aged ; Neoplasm Proteins - immunology ; Neoplasms - complications ; Neoplasms - diagnosis ; Neoplasms - drug therapy ; Nerve Degeneration - etiology ; Nerve Degeneration - pathology ; Nerve Fibers, Myelinated - pathology ; Nerve Fibers, Unmyelinated - pathology ; Nerve Tissue Proteins - immunology ; Nervous system (semeiology, syndromes) ; Neural Conduction ; Neuralgia - etiology ; Neurology ; Paraneoplastic Cerebellar Degeneration - etiology ; Paraneoplastic Cerebellar Degeneration - immunology ; Paraneoplastic Cerebellar Degeneration - physiopathology ; Paraneoplastic Polyneuropathy - classification ; Paraneoplastic Polyneuropathy - complications ; Paraneoplastic Polyneuropathy - immunology ; Paraneoplastic Polyneuropathy - physiopathology ; Reflex, Abnormal ; Sensation Disorders - etiology ; Sensation Disorders - pathology ; Sural Nerve - pathology ; Time Factors ; Tumors of the nervous system. Phacomatoses</subject><ispartof>Neurology, 2007-08, Vol.69 (6), p.564-572</ispartof><rights>2007 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c444t-f9ee56e424d386614486cfdba9d6465a74a0304bb815a6642c6e68c567463d353</citedby><cites>FETCH-LOGICAL-c444t-f9ee56e424d386614486cfdba9d6465a74a0304bb815a6642c6e68c567463d353</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=19017434$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17679675$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>OKI, Y</creatorcontrib><creatorcontrib>KOIKE, H</creatorcontrib><creatorcontrib>YAZAKI, S</creatorcontrib><creatorcontrib>NOKURA, K</creatorcontrib><creatorcontrib>YAMAMOTO, H</creatorcontrib><creatorcontrib>SOBUE, G</creatorcontrib><creatorcontrib>IIJIMA, M</creatorcontrib><creatorcontrib>MORI, K</creatorcontrib><creatorcontrib>HATTORI, N</creatorcontrib><creatorcontrib>KATSUNO, M</creatorcontrib><creatorcontrib>NAKAMURA, T</creatorcontrib><creatorcontrib>HIRAYAMA, M</creatorcontrib><creatorcontrib>TANAKA, F</creatorcontrib><creatorcontrib>SHIRAISHI, M</creatorcontrib><title>Ataxic vs painful form of paraneoplastic neuropathy</title><title>Neurology</title><addtitle>Neurology</addtitle><description>To characterize the clinicopathologic features of ataxic and painful forms of paraneoplastic neuropathy. Clinical, electrophysiologic, and histopathologic findings were assessed in 17 patients with paraneoplastic neuropathy. Clinical features can be categorized into two groups: one group (13 patients) with predominantly deep sensory disturbance and a second group (4 patients) with predominantly superficial sensory disturbance. The former group showed severe sensory ataxia and predominantly large myelinated fiber loss in the sural nerve. The latter group showed marked pain, in particular, severe mechanical hyperalgesia, and predominantly small myelinated and unmyelinated fiber loss. Nerve conduction assessment indicated an axonal neuropathy pattern in both groups, while sensory action potentials were more markedly diminished in the sensory ataxic form. Anti-Hu antibodies were detected in half of the patients in both groups. Treatment for cancer was effective to improve or stabilize neuropathic symptoms in some cases from both groups. Immunotherapy was effective only for a short time. Paraneoplastic neuropathy can be characterized into two groups by the presence of sensory ataxia or severe spontaneous pain and severe mechanical hyperalgesia. Preferential small myelinated and unmyelinated fiber loss correlated to the cases of severe pain.</description><subject>Action Potentials</subject><subject>Aged</subject><subject>Antibodies, Neoplasm - immunology</subject><subject>Antineoplastic Agents - therapeutic use</subject><subject>Autoantibodies - immunology</subject><subject>Autoantigens - immunology</subject><subject>Biological and medical sciences</subject><subject>Biopsy</subject><subject>Cranial nerves. Spinal roots. Peripheral nerves. Autonomic nervous system. Gustation. Olfaction</subject><subject>Female</subject><subject>Gait Ataxia - etiology</subject><subject>Humans</subject><subject>Hypesthesia - etiology</subject><subject>Hypesthesia - pathology</subject><subject>Lung Neoplasms - complications</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Neoplasm Proteins - immunology</subject><subject>Neoplasms - complications</subject><subject>Neoplasms - diagnosis</subject><subject>Neoplasms - drug therapy</subject><subject>Nerve Degeneration - etiology</subject><subject>Nerve Degeneration - pathology</subject><subject>Nerve Fibers, Myelinated - pathology</subject><subject>Nerve Fibers, Unmyelinated - pathology</subject><subject>Nerve Tissue Proteins - immunology</subject><subject>Nervous system (semeiology, syndromes)</subject><subject>Neural Conduction</subject><subject>Neuralgia - etiology</subject><subject>Neurology</subject><subject>Paraneoplastic Cerebellar Degeneration - etiology</subject><subject>Paraneoplastic Cerebellar Degeneration - immunology</subject><subject>Paraneoplastic Cerebellar Degeneration - physiopathology</subject><subject>Paraneoplastic Polyneuropathy - classification</subject><subject>Paraneoplastic Polyneuropathy - complications</subject><subject>Paraneoplastic Polyneuropathy - immunology</subject><subject>Paraneoplastic Polyneuropathy - physiopathology</subject><subject>Reflex, Abnormal</subject><subject>Sensation Disorders - etiology</subject><subject>Sensation Disorders - pathology</subject><subject>Sural Nerve - pathology</subject><subject>Time Factors</subject><subject>Tumors of the nervous system. Phacomatoses</subject><issn>0028-3878</issn><issn>1526-632X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkEtLxDAQgIMo7rr6F2QR9NaaNJNJ4k0WX7DgRcFbSNMUK91tbVp1_71Zt7BH5zIM882Dj5ALRlOWseyasvR7Xac0RoYxVEo5cpVqOCBTJjJMkGdvh2Qa-yrhSqoJOQnhg9LYlPqYTJhEqVGKKeG3vf2p3PwrzFtbrcuhnpdNt5o3Zaw7u_ZNW9vQR2Lth65pbf--OSVHpa2DPxvzjLze370sHpPl88PT4naZOADok1J7L9BDBgVXiAxAoSuL3OoCAYWVYCmnkOeKCYsImUOPygmUgLzggs_I1W5v2zWfgw-9WVXB-brevjUEg4px0FL-CzItZMYEjeDNDnRdE0LnS9N21cp2G8Oo2bo1lJno1uzdmj-3RkMcPh-vDPnKF_vRUWYELkfABmfrMupzVdhzmjIJHPgv38OBww</recordid><startdate>20070807</startdate><enddate>20070807</enddate><creator>OKI, Y</creator><creator>KOIKE, H</creator><creator>YAZAKI, S</creator><creator>NOKURA, K</creator><creator>YAMAMOTO, H</creator><creator>SOBUE, G</creator><creator>IIJIMA, M</creator><creator>MORI, K</creator><creator>HATTORI, N</creator><creator>KATSUNO, M</creator><creator>NAKAMURA, T</creator><creator>HIRAYAMA, M</creator><creator>TANAKA, F</creator><creator>SHIRAISHI, M</creator><general>Lippincott Williams &amp; Wilkins</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>20070807</creationdate><title>Ataxic vs painful form of paraneoplastic neuropathy</title><author>OKI, Y ; KOIKE, H ; YAZAKI, S ; NOKURA, K ; YAMAMOTO, H ; SOBUE, G ; IIJIMA, M ; MORI, K ; HATTORI, N ; KATSUNO, M ; NAKAMURA, T ; HIRAYAMA, M ; TANAKA, F ; SHIRAISHI, M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c444t-f9ee56e424d386614486cfdba9d6465a74a0304bb815a6642c6e68c567463d353</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Action Potentials</topic><topic>Aged</topic><topic>Antibodies, Neoplasm - immunology</topic><topic>Antineoplastic Agents - therapeutic use</topic><topic>Autoantibodies - immunology</topic><topic>Autoantigens - immunology</topic><topic>Biological and medical sciences</topic><topic>Biopsy</topic><topic>Cranial nerves. Spinal roots. Peripheral nerves. Autonomic nervous system. Gustation. Olfaction</topic><topic>Female</topic><topic>Gait Ataxia - etiology</topic><topic>Humans</topic><topic>Hypesthesia - etiology</topic><topic>Hypesthesia - pathology</topic><topic>Lung Neoplasms - complications</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Neoplasm Proteins - immunology</topic><topic>Neoplasms - complications</topic><topic>Neoplasms - diagnosis</topic><topic>Neoplasms - drug therapy</topic><topic>Nerve Degeneration - etiology</topic><topic>Nerve Degeneration - pathology</topic><topic>Nerve Fibers, Myelinated - pathology</topic><topic>Nerve Fibers, Unmyelinated - pathology</topic><topic>Nerve Tissue Proteins - immunology</topic><topic>Nervous system (semeiology, syndromes)</topic><topic>Neural Conduction</topic><topic>Neuralgia - etiology</topic><topic>Neurology</topic><topic>Paraneoplastic Cerebellar Degeneration - etiology</topic><topic>Paraneoplastic Cerebellar Degeneration - immunology</topic><topic>Paraneoplastic Cerebellar Degeneration - physiopathology</topic><topic>Paraneoplastic Polyneuropathy - classification</topic><topic>Paraneoplastic Polyneuropathy - complications</topic><topic>Paraneoplastic Polyneuropathy - immunology</topic><topic>Paraneoplastic Polyneuropathy - physiopathology</topic><topic>Reflex, Abnormal</topic><topic>Sensation Disorders - etiology</topic><topic>Sensation Disorders - pathology</topic><topic>Sural Nerve - pathology</topic><topic>Time Factors</topic><topic>Tumors of the nervous system. Phacomatoses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>OKI, Y</creatorcontrib><creatorcontrib>KOIKE, H</creatorcontrib><creatorcontrib>YAZAKI, S</creatorcontrib><creatorcontrib>NOKURA, K</creatorcontrib><creatorcontrib>YAMAMOTO, H</creatorcontrib><creatorcontrib>SOBUE, G</creatorcontrib><creatorcontrib>IIJIMA, M</creatorcontrib><creatorcontrib>MORI, K</creatorcontrib><creatorcontrib>HATTORI, N</creatorcontrib><creatorcontrib>KATSUNO, M</creatorcontrib><creatorcontrib>NAKAMURA, T</creatorcontrib><creatorcontrib>HIRAYAMA, M</creatorcontrib><creatorcontrib>TANAKA, F</creatorcontrib><creatorcontrib>SHIRAISHI, M</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>OKI, Y</au><au>KOIKE, H</au><au>YAZAKI, S</au><au>NOKURA, K</au><au>YAMAMOTO, H</au><au>SOBUE, G</au><au>IIJIMA, M</au><au>MORI, K</au><au>HATTORI, N</au><au>KATSUNO, M</au><au>NAKAMURA, T</au><au>HIRAYAMA, M</au><au>TANAKA, F</au><au>SHIRAISHI, M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ataxic vs painful form of paraneoplastic neuropathy</atitle><jtitle>Neurology</jtitle><addtitle>Neurology</addtitle><date>2007-08-07</date><risdate>2007</risdate><volume>69</volume><issue>6</issue><spage>564</spage><epage>572</epage><pages>564-572</pages><issn>0028-3878</issn><eissn>1526-632X</eissn><coden>NEURAI</coden><abstract>To characterize the clinicopathologic features of ataxic and painful forms of paraneoplastic neuropathy. Clinical, electrophysiologic, and histopathologic findings were assessed in 17 patients with paraneoplastic neuropathy. Clinical features can be categorized into two groups: one group (13 patients) with predominantly deep sensory disturbance and a second group (4 patients) with predominantly superficial sensory disturbance. The former group showed severe sensory ataxia and predominantly large myelinated fiber loss in the sural nerve. The latter group showed marked pain, in particular, severe mechanical hyperalgesia, and predominantly small myelinated and unmyelinated fiber loss. Nerve conduction assessment indicated an axonal neuropathy pattern in both groups, while sensory action potentials were more markedly diminished in the sensory ataxic form. Anti-Hu antibodies were detected in half of the patients in both groups. Treatment for cancer was effective to improve or stabilize neuropathic symptoms in some cases from both groups. Immunotherapy was effective only for a short time. Paraneoplastic neuropathy can be characterized into two groups by the presence of sensory ataxia or severe spontaneous pain and severe mechanical hyperalgesia. Preferential small myelinated and unmyelinated fiber loss correlated to the cases of severe pain.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott Williams &amp; Wilkins</pub><pmid>17679675</pmid><doi>10.1212/01.wnl.0000266668.03638.94</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0028-3878
ispartof Neurology, 2007-08, Vol.69 (6), p.564-572
issn 0028-3878
1526-632X
language eng
recordid cdi_proquest_miscellaneous_68134977
source MEDLINE; Journals@Ovid Complete; Alma/SFX Local Collection
subjects Action Potentials
Aged
Antibodies, Neoplasm - immunology
Antineoplastic Agents - therapeutic use
Autoantibodies - immunology
Autoantigens - immunology
Biological and medical sciences
Biopsy
Cranial nerves. Spinal roots. Peripheral nerves. Autonomic nervous system. Gustation. Olfaction
Female
Gait Ataxia - etiology
Humans
Hypesthesia - etiology
Hypesthesia - pathology
Lung Neoplasms - complications
Male
Medical sciences
Middle Aged
Neoplasm Proteins - immunology
Neoplasms - complications
Neoplasms - diagnosis
Neoplasms - drug therapy
Nerve Degeneration - etiology
Nerve Degeneration - pathology
Nerve Fibers, Myelinated - pathology
Nerve Fibers, Unmyelinated - pathology
Nerve Tissue Proteins - immunology
Nervous system (semeiology, syndromes)
Neural Conduction
Neuralgia - etiology
Neurology
Paraneoplastic Cerebellar Degeneration - etiology
Paraneoplastic Cerebellar Degeneration - immunology
Paraneoplastic Cerebellar Degeneration - physiopathology
Paraneoplastic Polyneuropathy - classification
Paraneoplastic Polyneuropathy - complications
Paraneoplastic Polyneuropathy - immunology
Paraneoplastic Polyneuropathy - physiopathology
Reflex, Abnormal
Sensation Disorders - etiology
Sensation Disorders - pathology
Sural Nerve - pathology
Time Factors
Tumors of the nervous system. Phacomatoses
title Ataxic vs painful form of paraneoplastic neuropathy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T10%3A59%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ataxic%20vs%20painful%20form%20of%20paraneoplastic%20neuropathy&rft.jtitle=Neurology&rft.au=OKI,%20Y&rft.date=2007-08-07&rft.volume=69&rft.issue=6&rft.spage=564&rft.epage=572&rft.pages=564-572&rft.issn=0028-3878&rft.eissn=1526-632X&rft.coden=NEURAI&rft_id=info:doi/10.1212/01.wnl.0000266668.03638.94&rft_dat=%3Cproquest_cross%3E68134977%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=19572150&rft_id=info:pmid/17679675&rfr_iscdi=true